Atossa Therapeutics, Inc.
ATOS • NASDAQ
Atossa Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Steven C. Quay, with a market cap of $40.6M.
CEOSteven C. Quay
Next Earnings
Upcoming earnings announcement for Atossa Therapeutics, Inc.
Date
Tuesday, May 12, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.11
Earnings History
Past 12 earnings reports for Atossa Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 25, 2026 | Q4 2025 | -$0.03Est: -$1.11 | +97.3% | - | — | — |
| Nov 12, 2025 | Q3 2025 | -$0.07Est: -$0.07 | 0.0% | - | — |  10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.07Est: -$0.06 | -16.7% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.05Est: -$0.05 | 0.0% | - | — | 10-Q |
| Mar 25, 2025 | Q4 2024 | -$0.05Est: -$0.06 | +16.7% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.06Est: -$0.06 | 0.0% | - | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.05Est: -$0.06 | +16.7% | - | — | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.05Est: -$0.07 | +28.6% | - | — | 10-Q |
| Apr 1, 2024 | Q4 2023 | -$0.06Est: -$0.05 | -20.0% | - | — | — |
| Nov 14, 2023 | Q3 2023 | -$0.05Est: -$0.07 | +28.6% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.08Est: -$0.06 | -33.3% | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.05Est: -$0.06 | +16.7% | - | — | 10-Q |